Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 3, 2022 | Series A | $10M | 1 |
|
— | Detail |
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 3, 2017
Swiftly
|
Series Unknown | $2.50M | Analytics | — |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |